Cellebrite DI (CLBT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cellebrite DI Ltd., a global leader in digital investigative solutions, has successfully completed the redemption of all outstanding warrants, with nearly 99.4% of Public Warrants and all Private Placement Warrants exercised, resulting in millions of new Ordinary Shares being issued. The redemption led to the delisting of Public Warrants from Nasdaq, while the company’s Ordinary Shares continue to trade under the ticker ‘CLBT’. This financial move reflects the company’s progress since its business combination in 2021 and remains unconnected to the sale of securities in any jurisdiction.
For further insights into CLBT stock, check out TipRanks’ Stock Analysis page.